Aggressive lipid-lowering therapy and regression of coronary atheroma

被引：0
|
作者：
Rosch, PJ
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 01期
关键词：
D O I：
10.1001/jama.292.1.38-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [21] The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
    Yingrui Li
    Songbai Deng
    Bin Liu
    Yulin Yan
    Jianlin Du
    Yu Li
    Xiaodong Jing
    Yajie Liu
    Jing Wang
    Jun Du
    Qiang She
    Scientific Reports, 11
  • [22] Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studies
    Gragnano, Felice
    Calabro, Paolo
    ATHEROSCLEROSIS, 2018, 269 : 219 - 228
  • [23] The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
    Li, Yingrui
    Deng, Songbai
    Liu, Bin
    Yan, Yulin
    Du, Jianlin
    Li, Yu
    Jing, Xiaodong
    Liu, Yajie
    Wang, Jing
    Du, Jun
    She, Qiang
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Effect of aggressive lipid-lowering therapy with rosuvastatin on reduction of coronary plaque in Japanese patients: APOLLO study
    Amemiya, K.
    Yokoi, H.
    Iwabuchi, M.
    Nobuyoshi, M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 185 - 185
  • [25] AGGRESSIVE LIPID-LOWERING THERAPY USING ROSUVASTATIN IMPROVES ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE
    Takayama, Tadateru
    Hiro, Takafumi
    Higuchi, Yoshiharu
    Yoda, Shunichi
    Kunimoto, Satoshi
    Yajima, Yoshiharu
    Hirayama, Atsushi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1630 - A1630
  • [26] A pharmacoeconomic evaluation of aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease in Spain
    Domingo, E
    Macaya, C
    Fernandez, I
    Rejas, J
    Hernández, G
    VALUE IN HEALTH, 2002, 5 (06) : 486 - 486
  • [27] Regression of coronary atherosclerosis in patients with coronary artery disease and normal cholesterol by intensive lipid-lowering therapy with pravastatin
    Ueno, T
    Ikeda, H
    Ueyama, T
    Eguchi, H
    Kato, A
    Mori, E
    Ichiki, K
    Hashino, T
    Haramaki, N
    Imaizumi, T
    CIRCULATION, 1997, 96 (08) : 2202 - 2202
  • [28] THE ANGIOGRAPHIC EVIDENCE FOR LIPID-LOWERING EFFECTS IN HUMAN CORONARY ATHEROSCLEROSIS REGRESSION
    BLANKENHORN, DH
    CURRENT OPINION IN CARDIOLOGY, 1991, 6 (04) : 574 - 580
  • [29] Regression of coronary atherosclerosis in patients with coronary artery disease and normal cholesterol, less than 180 mg/dl by aggressive lipid-lowering therapy with pravastatin.
    Ueno, T
    Ikeda, H
    Kai, H
    Murohara, T
    Hashino, T
    Haramaki, N
    Eguchi, H
    Kato, A
    Takajo, Y
    Onitsuka, I
    CIRCULATION, 1998, 98 (17) : 534 - 534
  • [30] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334
12345